Navigation Links
BioSpain 2010 Will Host 2,000 Business Meetings in Which More Than 600 Companies Will Come Together

BioSpain 2010 Will Host 2,000 Business Meetings in Which More Than 600 Companies... -- MADRID, September 23, 2010 /PRNewswire/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Trade Show News Click to view news release full screen  

BioSpain 2010 Will Host 2,000 Business Meetings in Which More Than 600 Companies Will Come Together


MADRID, September 23, 2010 /PRNewswire/ -- BioSpain 2010 will host 2,000 business meetings, 135% more than the previous event, between more than 600 companies, 25% of which are not Spanish. This percentage includes 150 foreign companies and institutions, which have decided to come to Spain to find new business opportunities within the biotechnology sector. This figure has increased by 60% as compared to the number of foreign companies that attended BioSpain 2008.

These figures turn BioSpain into the most important biotechnology-related event held by a Southern European country and it has also become a pioneer in Spain regarding the introduction of the partnering system whereby bilateral meetings between companies are fostered.

Pamplona will be the host city for this fifth BioSpain event ( to be held from September 29th to October 1st. This biannual event is organised by the Spanish Association of Biocompanies (ASEBIO) and on this occasion it also has the collaboration of the Navarre Government, through the Navarre Development Association (SODENA) with a view to disseminating biotechnological knowledge in Spain and contributing to its development. In turn, the event will be officially sponsored by companies as prestigious as Merck, Zeltia, AB BIOTICS, Genetrix, Genoma Espana, Caja Navarra and ICEX. The event is expected to be attended by more than 1,200 participants.

BioSpain 2010 will have 132 stands in the commercial exhibition, 15% more than on the previous event. These stands will provide room for 160 companies, 24% of which are not Spanish (38), which once again underlines the international spirit of this event as one of its highlights.

Furthermore, BioSpain 2010 will be honoured with the presence of three internationally acknowledged lecturers, such as Carlos Cordon-Cardo, Deputy Director of the Department of Pathology of Columbia University; Larry Fritz, CEO of Covella Pharmaceuticals and partner of the venture capital firm Westfield Capital Management, and Conny Bogentoft, CEO of Karolinska Development AB. Cordon-Cardo will explain the role of tumour stem cells; Larry Fritz will lecture on how to create and develop a successful biotechnology company and Bogentoft will explain how to materialise technological transfer, in other words, how to turn an idea into a business activity.

For additional information: Lucia Cecilia Mercado ASEBIO Communication Manager Phone No.: +34-91-210-93-74 Mobile: +34-663-117-293 Berbes Asociados Maribel Otero/Jorge Sanchez Phone No.: +34-91-563-23-00

Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. FOX Business Network Airing In-Depth Look at NeoStem
2. Safran Enters Into a Definitive Agreement With L-1 Identity Solutions for the Purchase of L-1 Biometrics and ID Management Solutions Businesses
3. Executive Mindshare Announces New Social Media Platform for Vertical Business Networks
4. Oxford Finance Corporation Hires Dr. Killu Sanborn to Support Life Science Business Development in Western North America
5. MabVax Therapeutics Receives Small Business Innovation Research Program Award from the National Cancer Institute
6. Simbionix Relocates its Courseware Business to its Corporate Headquarters in Cleveland, Ohio
7. Bilcare AG to Acquire INEOS Global Films Business for EUR100 Million
8. Orchestrall Sponsors China Business Toolbox: Brings Focus to the How and When of China Market Access
9. Lialda(R) - Shire Files Suit Against Cadila Healthcare Limited, Doing Business as Zydus Cadila and Zydus Pharmaceuticals (USA), Inc.
10. THE PLANNING SHOP international Announces Oncology Business Unit
11. Sirius Genomics Announces Appointment of Senior Director of Business Development
Post Your Comments:
(Date:10/12/2015)...  Rebiotix Inc. today announced that U.S. Food ... Microbiota Restoration Therapy (MRT) RBX2660 as a Breakthrough ... difficile (C diff) infection, a challenging to ... in the U.S. annually. 1 Rebiotix is ... to revolutionize the treatment of debilitating GI diseases ...
(Date:10/12/2015)... 12, 2015  Patara Pharma, a clinical-stage biotechnology ... diseases and conditions, today announced the closing of ... Concurrent with the close of its sale of ... and Security Agreement with Silicon Valley Bank whereby ... Patara will use the funds from the financing ...
(Date:10/12/2015)... ... October 12, 2015 , ... Dr. Carl Peck, MD, Chairman ... firm as a Premier Expert consultant. NDA Partners Premier Experts are top ... to the company's clients. Premier Experts collaborate to design and implement critical ...
(Date:10/10/2015)... 10 octobre 2015 Le 8 octobre, l,honorable Doris ... Registre du Congrès sa déclaration de soutien à ... autour du plasma (IPAW), qui se tiendra du ... Plasma Protein Therapeutics Association (PPTA) et ... , Sensibiliser l,opinion publique mondiale autour du ...
Breaking Biology Technology:
(Date:9/30/2015)... 30, 2015  The global glucose monitoring device and diabetes ... says a new report on the industry from Kalorama Information. Sales ... the market, followed by continuous glucose monitoring and sensor segment, ... market for these products in its latest report, The ... , ...
(Date:9/29/2015)... , Sept. 29, 2015  iDAvatars is excited to ... introduce its product to market. The official announcement was recently ... Economy event in San Francisco , ... platform powered by IBM Watson. "It is both ... first 100 companies to bring to market the cognitive power ...
(Date:9/28/2015)... 28, 2015  The monitoring of vital signs, ... temperature, is an essential component of patient assessment. ... deterioration in a patient,s condition. However, in general ... typically taken during routine observation rounds only once ... deteriorates between these observation rounds, the warning signs ...
Breaking Biology News(10 mins):